BIO 250117 420.00P (BIO250117P420000) Stock Options, News & Quotes

US OptionsDetailed Quotes

BIO250117P420000

Watchlist

0.00
0.000.00%

15min DelayClose Jan 17 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

We Think Bio-Rad Laboratories (NYSE:BIO) Can Stay On Top Of Its Debt
Simply Wall StJan 14 09:06 ET
RBC Capital Maintains Bio-Rad Laboratories(BIO.US) With Buy Rating, Maintains Target Price $481
Moomoo NewsJan 14 07:36 ET · Ratings
Growth Trends in the Pediatric Cancer Biomarkers Market, 2024-2034 - Roche, Thermo Fisher Scientific, Illumina, QIAGEN, and Bio-Rad Laboratories Dominate the Competition
Yahoo FinanceJan 9 04:28 ET
Geneoscopy Closes $105M in Series C Funding Round to Power Next-Generation of Gastrointestinal Diagnostic Tests
BusinesswireJan 8 08:15 ET
Bio-Rad's Management to Host Investor Meetings at J.P. Morgan's 43rd Annual Healthcare Conference
BusinesswireJan 2 16:30 ET
At US$331, Is It Time To Put Bio-Rad Laboratories, Inc. (NYSE:BIO) On Your Watch List?
Yahoo FinanceDec 26, 2024 08:47 ET

Comments

Moomoo Recap US

Sep 9, 2024 15:45

Columns Wall Street Today | Monday Market Climbs But Not Past Last Weeks Fall

The market advanced on Monday, following a tough start to September, the last month of Q3.
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded up 1.16% the $Dow Jones Industrial Average (.DJI.US)$ climbed 1.20%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 1.16%.
MACRO
This week in macro, investors are waiting for slimmer pickings during the blackout period for Fed press commentary. FOMC members are barre...

Palantir and Dell join S&P 500: Future stars or just hype?

Luzi Ann Santos

Sep 9, 2024 11:14

Columns Palantir Sees Heavy Trading for $35 Call Options as Stock Jumps on Inclusion to S&P 500

$Palantir (PLTR.US)$ is seeing heavier trading on call options that give the holders the right to buy the stock at $35 ahead of its inclusion into the S&P 500 index.
The stock jumped as much as 12.9% Monday to $34.23, the highest since early 2021. That share price rally moved the $35 call options closer to being in-the-money, sending the price of the contract soaring more than 200%.
More than 86,000 call opt...

Palantir and Dell join S&P 500: Future stars or just hype?

Kevin Travers

Sep 9, 2024 10:07

Columns Moovin Stonks | Market on the Rise, Meme Stocks Climbing

Good morning, traders. Happy Monday, September 9th. The market is climbing after last week's rough start to September. My name is Kevin Travers; here are stories about the U.S. stock market today.
$Palantir (PLTR.US)$ climbed 12% Monday after the joint S&P Dow Jones Indices group announced the firm would replace $American Airlines (AAL.US)$ on the S&P 500 before Sept. 23. It was not the only stock swap: $Dell Technologies (DELL.US)$ will repla...

Trump trade: Bitcoin hit record highs and Tesla hits $1 trillion market cap

Stock_Drift

Sep 8, 2024 13:28

$Palantir (PLTR.US)$ $Dell Technologies (DELL.US)$ $American Airlines (AAL.US)$ $Etsy Inc (ETSY.US)$ $Bio-Rad Laboratories (BIO.US)$ $Erie Indemnity (ERIE.US)$
📊⚡️📊

Moomoo AI

Jan 18, 2024 13:24

Despite a superior revenue outlook, the company isn't trading at a higher P/S due to potential risks like not meeting analysts' revenue projections in tough industry conditions. Investors anticipate future revenue volatility.

Take Care Before Diving Into The Deep End On Bio-Rad Laboratories, Inc. (NYSE:BIO)